• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The efficiency of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.肝门部胆管癌肝切除术后肝功能衰竭的发生率及死亡风险评分
Hepatobiliary Surg Nutr. 2022 Aug;11(4):643-644. doi: 10.21037/hbsn-22-228.
2
Major hepatectomies for perihilar cholangiocarcinoma: Predictors for clinically relevant postoperative complications using the International Study Group of Liver Surgery definitions.肝门部胆管癌的大范围肝切除术：依据国际肝脏手术研究组的定义分析临床相关术后并发症的预测因素
Asian J Surg. 2016 Apr;39(2):81-9. doi: 10.1016/j.asjsur.2015.04.007. Epub 2015 Jun 20.
3
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.对肝门部胆管癌进行的连续102例肝胆切除术，死亡率为零。
Ann Surg. 2006 Aug;244(2):240-7. doi: 10.1097/01.sla.0000217605.66519.38.
4
Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study.肝切除术治疗肝门部胆管癌：胆道引流失败对术后结果的影响。一项意大利多中心研究的结果。
Surgery. 2021 Aug;170(2):383-389. doi: 10.1016/j.surg.2021.01.021. Epub 2021 Feb 20.
5
Primary and secondary liver failure after major liver resection for perihilar cholangiocarcinoma.肝门部胆管癌根治性切除术后发生原发性和继发性肝衰竭。
Surgery. 2021 Oct;170(4):1024-1030. doi: 10.1016/j.surg.2021.04.013. Epub 2021 May 18.
6
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.肝门部胆管癌肝切除术后肝功能衰竭及死亡风险评分的验证研究
Hepatobiliary Surg Nutr. 2022 Jun;11(3):375-385. doi: 10.21037/hbsn-20-660.
7
Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.肝门部胆管癌和远端胆管癌根治性切除术后预后因素及复发模式的差异
Scand J Surg. 2020 Sep;109(3):219-227. doi: 10.1177/1457496919832150. Epub 2019 Feb 21.
8
Risk prediction of post-hepatectomy liver failure in patients with perihilar cholangiocarcinoma.肝门部胆管癌患者肝切除术后肝功能衰竭的风险预测。
J Gastroenterol Hepatol. 2018 Apr;33(4):958-965. doi: 10.1111/jgh.13966. Epub 2018 Jan 26.
9
Preoperative Bilirubin Level Predicts Overall Survival and Tumor Recurrence After Resection for Perihilar Cholangiocarcinoma Patients.术前胆红素水平可预测肝门部胆管癌患者切除术后的总生存期和肿瘤复发情况。
Cancer Manag Res. 2019 Dec 2;11:10157-10165. doi: 10.2147/CMAR.S230620. eCollection 2019.
10
Major hepatectomy for perihilar cholangiocarcinoma.肝门部胆管癌的根治性肝切除术。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):463-9. doi: 10.1007/s00534-009-0206-3. Epub 2009 Nov 26.

本文引用的文献

1
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.肝门部胆管癌肝切除术后肝功能衰竭及死亡风险评分的验证研究
Hepatobiliary Surg Nutr. 2022 Jun;11(3):375-385. doi: 10.21037/hbsn-20-660.
2
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.术后肝功能衰竭风险评分：识别可从门静脉栓塞中获益的可切除肝门部胆管癌患者。
J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4.
3
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant.肝门部胆管癌肝切除术后的死亡率：风险评分的制定及未来肝残余量胆汁引流的重要性
J Am Coll Surg. 2016 Aug;223(2):321-331.e1. doi: 10.1016/j.jamcollsurg.2016.03.035. Epub 2016 Apr 5.

The efficiency of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

作者信息

Feng Qingbo, Liao Wenwei, Li Jiaxin, Zeng Yong

机构信息

Department of Liver Surgery & Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.

出版信息

Hepatobiliary Surg Nutr. 2022 Aug;11(4):643-644. doi: 10.21037/hbsn-22-228.

DOI:10.21037/hbsn-22-228
PMID:36016736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396093/
Abstract
摘要